Blood Cancers
Cancer Journey

Welcome Home Sidebar Block

 

 

VIDEO LIBRARIES

ASCO 2016 - New Trials of Targeted Therapies to Treat Leptomeningeal Carcinomatosis

GRACE is happy to present the 9th and final video in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer...

ASCO 2016 - Promising Early Results for Treatments Targeting New Mutations

GRACE is happy to present the 8th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West...

ASCO 2016 - Immuno-oncology Developments - Combinations and Use as First-Line Therapy

GRACE is happy to present the 7th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West...

ASCO 2016 - Does Current Evidence Support Favoring Proton-Beam Radiation?

GRACE is happy to present the 6th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West...

ASCO 2016 - J-ALEX Trial: Should Alecensa Replace Xalkori as first-Line ALK Therapy

GRACE is happy to present the 5th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer. Featuring Jack West...

ARTICLES

Drs. Ross Camidge and Corey Langer on "Which patients do you send molecular marker testing for?"

Drs. Ross Camidge and Corey Langer describe which patients with advanced NSCLC they seek molecular marker testing on. [powerpress]

RTOG 0617: Stunningly Worse Survival for High Dose Radiation in Locally Advanced NSCLC, but Carbo-Taxol Has Never Looked Better

The Radiation Therapy Oncology Group (RTOG) has been working on a large randomized trial in patients with stage III, locally advanced, unresectable...

Is there a place for maintenance therapy in extensive stage SCLC?

Drs. Mary Pinder, Nate Pennell, and Jack West discuss whether the finding of improving progression-free survival with maintenance sorafenib for SCLC...

Dr. Greg Riely: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?

Dr. Greg Riely, from Memorial Sloan-Kettering, gives her view on more widespread availability of new mutation tests. [powerpress]

How should we integrate new immunotherapies into treatment strategies for lung cancer?

Drs. Jack West, Mary Pinder, and Nate Pennell review various ways in which emerging immunotherapies could be effectively incorporated into our...

COMMUNITY FORUM

Breast - 1294199

Greetings, it has been 5 years since I noticed this brownish thing on my areola. At first, i thought it was dirt or something so I tried to remove it...

Shortness of Breath While On Tagrisso? - 1294196

My mother was diagnosed with stage 4 lung cancer and currently on Tagrisso. She said that the experiencing shortness of breath on certain days while...

Relationship between anti-depressant use and lung cancer survival - 1294191

The article linked below suggests that using specific types of anti-depressants (tricyclic and NDRI's) increases survival in lung cancer in both...

Immunotherapy treatment of EGFR/T790M after progression - 1294190

Answers to previous posts and other source of information have indicated that "Patients with EGFR do not respond as well to immunotherapy as others...

Clinical Trials - GRACE wants to hear from you! - 1294184

Hello GRACE Community! We would like some feedback. On our new site - hopefully launched as soon as we can secure the funding to get us up and running...

Subscribe to Blood Cancers